Position in LLY
as of Jun 30, 2026
· filed Jul 2, 2026
Position Value
$4,272,370
+$1,010,866 QoQ
Shares Held
3,562
+0.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.70%
of 13F equity value
Holder Rank
#695
of 2,124 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Versant Capital Management, Inc holds $22,172,877 across 17 Drug Manufacturers - General names. LLY ranks #1 (19.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
3,562 | $4,272,370 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
73,361 | $4,227,060 | |
| 3 | JNJ |
Johnson & Johnson
|
13,834 | $3,513,420 | |
| 4 | ABBV |
AbbVie Inc.
|
6,899 | $1,736,064 | |
| 5 | NVS |
Novartis AG
|
10,771 | $1,688,031 | |
| 6 | MRK |
Merck & Co., Inc.
|
12,085 | $1,552,922 | |
| 7 | AZN |
Astrazeneca PLC
|
7,263 | $1,377,210 | |
| 8 | AMGN |
Amgen Inc
|
1,980 | $716,997 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,272,370 | 3,562 | Shares | Sole | 2026-07-02 | |
| 2026-03-31 | $3,261,504 | 3,546 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $2,996,208 | 2,788 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $1,724,380 | 2,260 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $1,182,547 | 1,517 | Shares | Sole | 2025-07-07 | |
| 2025-03-31 | $1,619,609 | 1,961 | Shares | Sole | 2025-04-03 | |
| 2024-12-31 | $900,924 | 1,167 | Shares | Sole | 2025-01-03 | |
| 2024-09-30 | $867,335 | 979 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $810,315 | 895 | Shares | Sole | 2024-07-08 | |
| 2024-03-31 | $572,578 | 736 | Shares | Sole | 2024-04-03 | |
| 2023-12-31 | $421,451 | 723 | Shares | Sole | 2024-01-08 | |
| 2023-09-30 | $396,401 | 738 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $348,452 | 743 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $256,878 | 748 | Shares | Sole | 2023-04-10 | |
| 2022-12-31 | $165,359 | 452 | Shares | Sole | 2023-01-25 | |
| 2022-09-30 | $151,651 | 469 | Shares | Sole | 2022-12-30 | |
| 2022-06-30 | $152,712 | 471 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $134,880 | 471 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $130,099 | 471 | Shares | Sole | 2022-01-06 | |
| 2021-09-30 | $108,824 | 471 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $113,382 | 494 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $11,782,550 | 63,069 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $10,664,947 | 63,166 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $9,571,861 | 64,666 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $10,616,863 | 64,666 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $8,971,854 | 64,676 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||